Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of brostallicin in combination with cisplatin in patients with treatment-resistant solid tumours

X
Trial Profile

Effects of brostallicin in combination with cisplatin in patients with treatment-resistant solid tumours

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 11 May 2011

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Brostallicin (Primary) ; Cisplatin
  • Indications Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 May 2011 Status changed from planning to completed.
    • 20 Nov 2007 Preliminary results were presented at the Highlights in Oncology meeting in Naples, Italy, on Tuesday, November 20, 2007.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top